Amy Dunn
Pediatric Hematology-Oncology · Columbus, OHNPI 1194756049
Payments from drug & device makers
Across 960 payments — averaging $1270.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$606K
- Bioverativ Therapeutics Inc.$279K
- Sanofi US Services Inc.$121K
- Novo Nordisk AS$63K
- Takeda Pharmaceuticals U.S.A., Inc.$47K
- HEMA Biologics, LLC$41K
- plus $62K from 12 others
Across 17 payments — averaging $409.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$3K
- F. Hoffmann-la Roche AG$2K
- Regeneron$2K
- Bioverativ Therapeutics Inc.$462
- Sanofi-aventis U.S. LLC$245
What the payments were for
- Consulting fees$65,34551%
- Speaking & faculty fees$26,98321%
- Travel & lodging$33,91226%
- Food & beverage$2,5782%
- Education$1640%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 137 | $606,054 |
| Bioverativ Therapeutics Inc. | 176 | $278,554 |
| Sanofi US Services Inc. | 33 | $121,388 |
| Novo Nordisk AS | 485 | $63,447 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $46,528 |
| HEMA Biologics, LLC | 53 | $41,245 |
| Regeneron | 6 | $26,081 |
| CSL Behring | 14 | $12,557 |
| Shire North American Group Inc | 8 | $8,850 |
| F. Hoffmann-la Roche AG | 1 | $4,445 |
| Sanofi | 6 | $3,250 |
| Kedrion Biopharma Inc. | 1 | $2,638 |
| Novo Nordisk | 2 | $2,185 |
| Pfizer | 5 | $1,436 |
| Genentech, Inc. | 1 | $495 |
| Genentech USA, Inc. | 1 | $109 |
| Baxter Healthcare | 3 | $44 |
| AbbVie | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SevenFact$39,718
- Idelvion$9,838
- Afstyla$7,278
- HEMLIBRA$4,554
- KOATE$2,638
- Roctavian$2,386
- HEMGENIX$2,247
- NovoSeven RT$2,160
- BENEFIX$1,400
- Non-Covered Product$495
How this compares
$1,219,323 in reported general payments places this provider in the 90th percentile of 143 pediatric hematology-oncology providers in Ohio.
Other pediatric hematology-oncology in Columbus
- Mark RanalliColumbus$3.1M
- Margot LazowColumbus$2.5M
- Maryam FouladiColumbus$2.3M
- Jeffery AulettaColumbus$708K
- Melissa RoseColumbus$485K
- Susan ColaceColumbus$251K
- Nilay ShahColumbus$195K
- Bryce KerlinColumbus$184K
- Anthony VillellaColumbus$123K
- Keri StrebyColumbus$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.